New drug combo shows promise for Tough-to-Treat liver cancer
Disease control
Not yet recruiting
This study tests a combination of two drugs, adebrelimab and apatinib, in people with advanced liver cancer that has worsened after previous treatments. The goal is to see if the combination can shrink tumors. About 47 adults with unresectable or metastatic liver cancer will rece…
Phase: PHASE2 • Sponsor: Song Peng • Aim: Disease control
Last updated May 11, 2026 20:38 UTC